Background <p>Hospital-acquired gram-negative bacterial (HA-GNB) infections are a leading cause of nosocomial morbidity and mortality, yet local epidemiological data to guide empirical therapy remain limited.</p> Methods <p>We conducted a retrospective cohort study of 377 adult patients with culture-confirmed invasive gram-negative infection acquired ≥ 48&#xa0;h after admission to King Abdulaziz Medical City (KAMC), Jeddah, Saudi Arabia (2020–2024). Demographics, comorbidities, infection type, microbiology, susceptibility, complications, and outcomes were analyzed using chi-square/Fisher’s exact tests and t-tests/Mann–Whitney U tests; multivariable logistic regression was used to identify independent predictors of multidrug-resistant (MDR) infection and in-hospital mortality. Infection types were classified according to U.S. Centers for Disease Control and Prevention / National Healthcare Safety Network (CDC/NHSN) surveillance definitions.</p> Results <p>Mean age was 64.6 ± 17.7 years (59.4% male). Hypertension (61.0%), diabetes (54.6%), and cardiovascular disease (40.8%) were the commonest comorbidities. Pneumonia predominated (47.1%), followed by bloodstream infection (33.0%), surgical-site infection (15.7%), and ventilator-associated pneumonia (9.6%). <i>Klebsiella pneumoniae</i> (41.9%), <i>Pseudomonas aeruginosa</i> (34.0%), and <i>Escherichia coli</i> (15.4%) were the predominant pathogens. Resistance was highest for ciprofloxacin (44.4%), ceftazidime (40.2%), and cefepime (39.9%), and 34.3% for meropenem. Overall morbidity was 68.6% and mortality 39.9%. Mortality was significantly higher in patients with cardiovascular disease (48.8% vs. 34.3%, <i>p</i> = 0.011), hypertension (45.4% vs. 31.5%, <i>p</i> = 0.015), and COPD (100.0% vs. 39.2%, <i>p</i> = 0.025). Diabetes was strongly associated with multidrug-resistant infection (OR 3.60, 95% CI 1.44–9.04; <i>p</i> = 0.004) and remained an independent predictor in multivariable logistic regression adjusting for age, sex, cardiovascular disease, and pneumonia (adjusted OR 2.82, 95% CI 1.11–7.17).</p> Conclusions <p>HA-GNB infections at this Saudi tertiary center are dominated by <i>K. pneumoniae</i> and <i>P. aeruginosa</i>, carry a roughly two-in-five case fatality, and show worrying resistance to commonly used empirical agents. Within the constraints of a single-center, retrospective design, these findings support local antibiogram-informed review of empirical protocols, continued antimicrobial stewardship, and heightened infection-control attention to high-risk subgroups, particularly patients with diabetes and cardiopulmonary comorbidities; confirmation in prospective, multi-center studies is warranted.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Clinical characteristics, causative organisms, and antimicrobial resistance profiles of hospital-acquired invasive gram-negative bacterial infections at a tertiary-care center in Saudi Arabia: a five-year retrospective cohort study (2020–2024)

  • Abdullah A. Awadh,
  • Anss A. Alshokani,
  • Abdullah O. Ezzaddin,
  • Abdullah F. Bintalib,
  • Maan T. Alwafi,
  • Amjad A. Alghamdi,
  • Sohaib F. Samkri,
  • Mohammed A. Khan

摘要

Background

Hospital-acquired gram-negative bacterial (HA-GNB) infections are a leading cause of nosocomial morbidity and mortality, yet local epidemiological data to guide empirical therapy remain limited.

Methods

We conducted a retrospective cohort study of 377 adult patients with culture-confirmed invasive gram-negative infection acquired ≥ 48 h after admission to King Abdulaziz Medical City (KAMC), Jeddah, Saudi Arabia (2020–2024). Demographics, comorbidities, infection type, microbiology, susceptibility, complications, and outcomes were analyzed using chi-square/Fisher’s exact tests and t-tests/Mann–Whitney U tests; multivariable logistic regression was used to identify independent predictors of multidrug-resistant (MDR) infection and in-hospital mortality. Infection types were classified according to U.S. Centers for Disease Control and Prevention / National Healthcare Safety Network (CDC/NHSN) surveillance definitions.

Results

Mean age was 64.6 ± 17.7 years (59.4% male). Hypertension (61.0%), diabetes (54.6%), and cardiovascular disease (40.8%) were the commonest comorbidities. Pneumonia predominated (47.1%), followed by bloodstream infection (33.0%), surgical-site infection (15.7%), and ventilator-associated pneumonia (9.6%). Klebsiella pneumoniae (41.9%), Pseudomonas aeruginosa (34.0%), and Escherichia coli (15.4%) were the predominant pathogens. Resistance was highest for ciprofloxacin (44.4%), ceftazidime (40.2%), and cefepime (39.9%), and 34.3% for meropenem. Overall morbidity was 68.6% and mortality 39.9%. Mortality was significantly higher in patients with cardiovascular disease (48.8% vs. 34.3%, p = 0.011), hypertension (45.4% vs. 31.5%, p = 0.015), and COPD (100.0% vs. 39.2%, p = 0.025). Diabetes was strongly associated with multidrug-resistant infection (OR 3.60, 95% CI 1.44–9.04; p = 0.004) and remained an independent predictor in multivariable logistic regression adjusting for age, sex, cardiovascular disease, and pneumonia (adjusted OR 2.82, 95% CI 1.11–7.17).

Conclusions

HA-GNB infections at this Saudi tertiary center are dominated by K. pneumoniae and P. aeruginosa, carry a roughly two-in-five case fatality, and show worrying resistance to commonly used empirical agents. Within the constraints of a single-center, retrospective design, these findings support local antibiogram-informed review of empirical protocols, continued antimicrobial stewardship, and heightened infection-control attention to high-risk subgroups, particularly patients with diabetes and cardiopulmonary comorbidities; confirmation in prospective, multi-center studies is warranted.